Anti-snoring Devices And Snoring Surgery Market Size, Trends, Share, Growth | Report 2022-2030
The global anti-snoring devices and snoring surgery market size was estimated at around USD 1.45 billion in 2021 and it is projected to hit around USD 2.8 billion by 2030, growing at a CAGR of 7.59% from 2022 to 2030.
Increasing focus on developing new products in the market by the key players is expected to boost the growth of the market. In addition, the ever-rising cases of snoring issues and sleep apnea are also expected to propel the growth of the market over the forecast period. For instance, according to the American Sleep Association, about 50-70 million U.S. adults have a sleep disorder and 48% of this report snoring.
Various restrictions laid down by the government as an attempt to curb the spread of the COVID-19 virus led to a major loss across the majority of industries. While the restriction on traveling and movement led to a major disruption in the supply of products and services, it also led to reduced patient visits to the hospitals and clinics. Thus, the pandemic had a huge impact on the healthcare industry. The global market felt a slight yet significant negative impact too. The reduced patient visits to the hospitals and clinics further led to a reduced number of patients seeking treatment for snoring. However, with the world returning to normalcy and manufacturers focusing on new and advanced product development, the market is expected to experience considerable growth over the forecast period.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 1.45 billion |
| Revenue Forecast by 2030 | USD 2.8 billion |
| Growth rate from 2022 to 2030 | CAGR of 7.59% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Type, region |
| Companies Covered |
Apnea Sciences Corp.; SomnoMed Ltd.; Airway Management, Inc.; ResMed Inc.; Fisher & Paykel Healthcare Corp. Ltd.; Koninklijke Philips NV; Sleep Well Enjoy Life, Ltd.; Tomed Dr. Toussaint GmbH; MEDiTAS Ltd. |
Type Insights
Based on type, the market is segmented into oral appliances/mouthpieces, nasal devices, position control devices, chin straps, tongue stabilizing devices, and EPAP therapy devices. The oral appliances/mouthpieces segment dominated the global market with a revenue share of 29.83% in 2021. Factors, such as growing adoption of and awareness about oral appliances/mouthpieces among dentists and patients and the launch of technologically advanced products. Oral appliances/mouthpieces are also recommended as the first line of treatment, which has resulted in the higher adoption rate of these devices compared to other anti-snoring devices.
The position-control devices segment is estimated to register the fastest CAGR from 2022 to 2030. The PAP therapy devices segment was the second-leading type segment, in terms of revenue, in 2021. One of the main factors driving the growth of this segment includes the launch of new products and the manufacturers’ efforts to increase their sales by entering into a distribution agreement with strong regional distributors. In addition, the EPAP therapy devices have shown tremendous potential in treating patients with snoring issues and obstructive sleep apnea, which represents a great growth opportunity for this segment over the forecast period.
Regional Insights
North America dominated the global market in 2021 and accounted for the largest share of more than 37.5% of the global revenue. This can be attributed to a large number of individuals experiencing snoring in the U.S. For instance, an estimated 45% of adults snore occasionally, while 25% snore regularly, according to an article published by John Hopkins University in 2022. Another research article by Sleep Foundation states that an estimated 57% of men and 40% of women in the U.S. are affected by snoring issues. It also stated that even an estimated 27% of children are affected. A major factor leading to a rise in the number of individuals being affected with snoring issues in the region is growing obesity.
Obesity is a major concern, especially in the U.S., caused mainly due to the growing adoption of a sedentary lifestyle and an increase in the consumption of processed foods. Moreover, the presence of market players in this region and the availability of products on e-commerce sites as well as in retail stores will boost the market penetration and product reach. Asia Pacific is anticipated to register the fastest CAGR from 2022 to 2030. The region represents high growth due to the presence of a large pool of untreated individuals with snoring issues and the rising awareness regarding this condition. Growing disposable income levels are also expected to boost the product demand in this region.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Anti-snoring Devices And Snoring Surgery Market
5.1. COVID-19 Landscape: Anti-snoring Devices And Snoring Surgery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1.List of Suppliers
7.1.3.2.List of Buyers
Chapter 8. Global Anti-snoring Devices And Snoring Surgery Market, By Type
8.1. Anti-snoring Devices And Snoring Surgery Market, by Type Type, 2020-2027
8.1.1. Oral Appliances/Mouthpieces
8.1.1.1.Market Revenue and Forecast (2016-2027)
8.1.2. Nasal Devices
8.1.2.1.Market Revenue and Forecast (2016-2027)
8.1.3. Position Control Devices
8.1.3.1.Market Revenue and Forecast (2016-2027)
8.1.4. Chin Straps
8.1.4.1.Market Revenue and Forecast (2016-2027)
8.1.5. Tongue Stabilizing Devices
8.1.5.1.Market Revenue and Forecast (2016-2027)
8.1.6. EPAP Therapy Devices
8.1.6.1.Market Revenue and Forecast (2016-2027)
Chapter 9. Global Anti-snoring Devices And Snoring Surgery Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Type (2016-2027)
9.1.2. U.S.
9.1.3. Rest of North America
9.1.3.1.Market Revenue and Forecast, by Type (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Type (2016-2027)
9.2.2. UK
9.2.2.1.Market Revenue and Forecast, by Type (2016-2027)
9.2.3. France
9.2.3.1.Market Revenue and Forecast, by Type (2016-2027)
9.2.4. Rest of Europe
9.2.4.1.Market Revenue and Forecast, by Type (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Type (2016-2027)
9.3.2. India
9.3.2.1.Market Revenue and Forecast, by Type (2016-2027)
9.3.3. China
9.3.3.1.Market Revenue and Forecast, by Type (2016-2027)
9.3.4. Japan
9.3.4.1.Market Revenue and Forecast, by Type (2016-2027)
9.3.5. Rest of APAC
9.3.5.1.Market Revenue and Forecast, by Type (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Type (2016-2027)
9.4.2. GCC
9.4.2.1.Market Revenue and Forecast, by Type (2016-2027)
9.4.3. North Africa
9.4.3.1.Market Revenue and Forecast, by Type (2016-2027)
9.4.4. South Africa
9.4.4.1.Market Revenue and Forecast, by Type (2016-2027)
9.4.5. Rest of MEA
9.4.5.1.Market Revenue and Forecast, by Type (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Type (2016-2027)
9.5.2. Brazil
9.5.2.1.Market Revenue and Forecast, by Type (2016-2027)
9.5.3. Rest of LATAM
9.5.3.1.Market Revenue and Forecast, by Type (2016-2027)
Chapter 10. Company Profiles
10.1.Apnea Sciences Corp.
10.1.1. Company Overview
10.1.2. Produvt offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2.SomnoMed Ltd.
10.2.1. Company Overview
10.2.2. Produvt offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3.Airway Management, Inc.
10.3.1. Company Overview
10.3.2. Produvt offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4.ResMed Inc.
10.4.1. Company Overview
10.4.2. Produvt offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5.Fisher & Paykel Healthcare Corp. Ltd.
10.5.1. Company Overview
10.5.2. Produvt offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6.Koninklijke Philips NV
10.6.1. Company Overview
10.6.2. Produvt offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7.Sleep Well Enjoy Life, Ltd.
10.7.1. Company Overview
10.7.2. Produvt offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8.Tomed Dr. Toussaint GmbH
10.8.1. Company Overview
10.8.2. Produvt offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9.MEDiTAS Ltd.
10.9.1. Company Overview
10.9.2. Produvt offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
Chapter 11. Research Methodology
11.1.Primary Research
11.2.Secondary Research
11.3.Assumptions
Chapter 12. Appendix
12.1.About Us
12.2.Glossary of Terms
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Anti-snoring Devices And Snoring Surgery Market
5.1. COVID-19 Landscape: Anti-snoring Devices And Snoring Surgery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1.List of Suppliers
7.1.3.2.List of Buyers
Chapter 8. Global Anti-snoring Devices And Snoring Surgery Market, By Type
8.1. Anti-snoring Devices And Snoring Surgery Market, by Type Type, 2020-2027
8.1.1. Oral Appliances/Mouthpieces
8.1.1.1.Market Revenue and Forecast (2016-2027)
8.1.2. Nasal Devices
8.1.2.1.Market Revenue and Forecast (2016-2027)
8.1.3. Position Control Devices
8.1.3.1.Market Revenue and Forecast (2016-2027)
8.1.4. Chin Straps
8.1.4.1.Market Revenue and Forecast (2016-2027)
8.1.5. Tongue Stabilizing Devices
8.1.5.1.Market Revenue and Forecast (2016-2027)
8.1.6. EPAP Therapy Devices
8.1.6.1.Market Revenue and Forecast (2016-2027)
Chapter 9. Global Anti-snoring Devices And Snoring Surgery Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Type (2016-2027)
9.1.2. U.S.
9.1.3. Rest of North America
9.1.3.1.Market Revenue and Forecast, by Type (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Type (2016-2027)
9.2.2. UK
9.2.2.1.Market Revenue and Forecast, by Type (2016-2027)
9.2.3. France
9.2.3.1.Market Revenue and Forecast, by Type (2016-2027)
9.2.4. Rest of Europe
9.2.4.1.Market Revenue and Forecast, by Type (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Type (2016-2027)
9.3.2. India
9.3.2.1.Market Revenue and Forecast, by Type (2016-2027)
9.3.3. China
9.3.3.1.Market Revenue and Forecast, by Type (2016-2027)
9.3.4. Japan
9.3.4.1.Market Revenue and Forecast, by Type (2016-2027)
9.3.5. Rest of APAC
9.3.5.1.Market Revenue and Forecast, by Type (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Type (2016-2027)
9.4.2. GCC
9.4.2.1.Market Revenue and Forecast, by Type (2016-2027)
9.4.3. North Africa
9.4.3.1.Market Revenue and Forecast, by Type (2016-2027)
9.4.4. South Africa
9.4.4.1.Market Revenue and Forecast, by Type (2016-2027)
9.4.5. Rest of MEA
9.4.5.1.Market Revenue and Forecast, by Type (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Type (2016-2027)
9.5.2. Brazil
9.5.2.1.Market Revenue and Forecast, by Type (2016-2027)
9.5.3. Rest of LATAM
9.5.3.1.Market Revenue and Forecast, by Type (2016-2027)
Chapter 10. Company Profiles
10.1.Apnea Sciences Corp.
10.1.1. Company Overview
10.1.2. Produvt offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2.SomnoMed Ltd.
10.2.1. Company Overview
10.2.2. Produvt offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3.Airway Management, Inc.
10.3.1. Company Overview
10.3.2. Produvt offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4.ResMed Inc.
10.4.1. Company Overview
10.4.2. Produvt offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5.Fisher & Paykel Healthcare Corp. Ltd.
10.5.1. Company Overview
10.5.2. Produvt offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6.Koninklijke Philips NV
10.6.1. Company Overview
10.6.2. Produvt offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7.Sleep Well Enjoy Life, Ltd.
10.7.1. Company Overview
10.7.2. Produvt offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8.Tomed Dr. Toussaint GmbH
10.8.1. Company Overview
10.8.2. Produvt offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9.MEDiTAS Ltd.
10.9.1. Company Overview
10.9.2. Produvt offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
Chapter 11. Research Methodology
11.1.Primary Research
11.2.Secondary Research
11.3.Assumptions
Chapter 12. Appendix
12.1.About Us
12.2.Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers